key: cord-0710943-rkxn981w
authors: Rudd, Jennifer M.; Selvan, Miruthula Tamil; Cowan, Shannon; Kao, Yun-Fan; Midkiff, Cecily C.; Ritchey, Jerry W.; Miller, Craig A.
title: Clinicopathologic features of a feline SARS-CoV-2 infection model parallel acute COVID-19 in humans
date: 2021-04-23
journal: bioRxiv
DOI: 10.1101/2021.04.14.439863
sha: 9e8aace28e976194a0e39771d63044cbbb51fbd9
doc_id: 710943
cord_uid: rkxn981w

The emergence and ensuing dominance of COVID-19 on the world stage has emphasized the urgency of efficient animal models for the development of therapeutics and assessment of immune responses to SARS-CoV-2 infection. Shortcomings of current animal models for SARS-CoV-2 include limited lower respiratory disease, divergence from clinical COVID-19 disease, and requirements for host genetic modifications to permit infection. This study validates a feline model for SARS-CoV-2 infection that results in clinical disease and histopathologic lesions consistent with severe COVID-19 in humans. Intra-tracheal inoculation of concentrated SARS-CoV-2 caused infected cats to develop clinical disease consistent with that observed in the early exudative phase of COVID-19. A novel clinical scoring system for feline respiratory disease was developed and utilized, documenting a significant degree of lethargy, fever, dyspnea, and dry cough in infected cats. In addition, histopathologic pulmonary lesions such as diffuse alveolar damage, hyaline membrane formation, fibrin deposition, and proteinaceous exudates were observed due to SARS-CoV-2 infection, imitating lesions identified in people hospitalized with ARDS from COVID-19. A significant correlation exists between the degree of clinical disease identified in infected cats and pulmonary lesions. Viral loads and ACE2 expression were quantified in nasal turbinates, distal trachea, lung, and various other organs. Natural ACE2 expression, paired with clinicopathologic correlates between this feline model and human COVID-19, encourage use of this model for future translational studies. Author Summary Identifying an ideal animal model to study COVID-19 has been difficult, and current models come with challenges that restrict their potential in translational studies. Few lab animals naturally express the receptors necessary for viral infection (ACE2), and many fail to manifest clinical signs or pathology similar to that seen in humans. Other models (non-human primates, mink) are ideal for disease and transmission studies, but are restricted by cost, husbandry challenges, and scarce availability. Alternatively, cats naturally express ACE2 receptors, are naturally infected with SARS-CoV-2 and can transmit virus from cat-to-cat. Prior to this study, cats infected by oral/nasal routes have not displayed significant clinical disease or lung pathology. However, we demonstrate that direct inoculation of concentrated SARS-CoV-2 virus in the trachea of cats induces analogous clinical and pathologic features to hospitalized patients with acute COVID-19. Our results show that infected cats exhibit significant clinical signs during experimental infection (coughing, increased respiratory effort, lethargy, and fever) and exhibit extensive lung lesions that mimic severe COVID-19 pathology such as diffuse alveolar damage and hyaline membrane formation – highlighting the immeasurable potential for this feline model to address translational approaches for COVID-19 and to better understand the role of cats in transmission and disease.

and exhibit extensive lung lesions that mimic severe COVID-19 pathology such as diffuse 48 alveolar damage and hyaline membrane formation -highlighting the immeasurable potential for 49 this feline model to address translational approaches for COVID-19 and to better understand the 50 role of cats in transmission and disease. 51

Since the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 54 in late 2019, Coronavirus Disease 2019 (COVID-19) has swept across the globe resulting in 55 nearly 3 million deaths worldwide as of March 2021 (1) . Although a wide range of clinical 56 symptoms are reported, mortality of COVID-19 patients is closely correlated with progression of 57 viral infection to severe lung disease (pneumonia) and respiratory failure due to acute respiratory 58 distress syndrome (ARDS), which is further complicated by immune cell dyscrasias and 59 hyperinflammation (cytokine storm) in critically ill patients (2-4). Features of pulmonary 60 pathology that are hallmarks of severe COVID-19 (i.e., diffuse alveolar damage with hyaline 61 membrane formation, type II pneumocyte hyperplasia, vascular thrombi, fibrin and serous 62 7 122 0 (Healthy) 1 2

No weight loss 0 to 5% weight loss > 5% weight loss was scored daily at the same time point (morning) by a small animal clinician (JMR). Cats were 127 assigned a score from 0 to 2 for each clinical parameter: body weight, temperature, respiratory 128 effort, activity, behavior, ocular/nasal discharge, coughing/wheezing. The parameter scores were 129 summed to assign an overall score per cat per day. Potential scores can range from 0 (healthy 130 with no signs of disease) to 14 on any given day. Resting respiratory rate was considered normal 131 if <36 breaths per minute. Marked increases in rate were >50 breaths per minute at rest. 132

Temperatures were obtained via thermal microchips, and body weights were obtained last to 133 limit stress affecting clinical scoring. 134

Complete post-mortem evaluation was performed for all sham-inoculated control animals 136 (n=6) and SARS-CoV-2-infected cats euthanized on day 4 (n=6) and day 8 (n=6) post-137 inoculation. Necropsy tissues from SARS-CoV-2-infected cats (including lung, trachea, nasal 138 turbinates, and tracheobronchial lymph node (TBLN)) were grossly examined and compared to 139 those from sham-inoculated cats (Fig 2 A-C) . At 4 dpi, the lungs of SARS-CoV-2-infected cats 140

were grossly heavy and wet, with large multifocal to coalescing regions of dark red consolidation 141 that exuded a moderate amount of edema upon cut section (Fig 2 B) . Gross lung lesions were 142 similar at 8 dpi in SARS-CoV-2-infected cats, although the degree of pulmonary edema was 143 moderately more pronounced (Fig 2 C) . The TBLN of all SARS-CoV-2-infected cats were 144 diffusely enlarged 4-5 times normal at both 4 dpi (n=6) and 8 dpi (n=6). 145

Microscopic evaluation of selected necropsy tissues (lung, trachea, nasal turbinates, TBLN, 146 and kidney) was performed for all study animals. Tissue sections from all sham-inoculated 147 animals (n=6) were histologically unremarkable (Fig 2 D and S2 Table) . In contrast, 148 histopathologic features of feline SARS-CoV-2 infection exhibited striking similarities to 149 documented pathologic features of the acute (exudative) and organizing phases of human 150 COVID-19 (34-37). At 4 dpi, 100% (6/6) of SARS-COV-2 -infected cats exhibited a significant 151 degree of lung pathology (interaction, p<0.0001) and prominent histologic features consistent 152 with diffuse alveolar damage (DAD) (Fig 2 E-F ). Pulmonary edema (5/6 cats), multifocal 153 alveolar damage and necrosis (5/6 cats), perivascular lymphocytic and neutrophilic infiltrates 154 (6/6 cats), and increased intra-alveolar macrophages (5/6 cats) were significantly elevated in 155 SARS-CoV-2-infected cats at 4 dpi (Supporting Information). These changes were occasionally 156 accompanied by multifocal areas of hyaline membrane formation (3/6 cats), mild to moderate 157 amounts of intra-alveolar fibrin (2/6 cats), type II pneumocyte hyperplasia (2/6 cats), and intra-158 alveolar syncytial cells (2/6 cats). One SARS-CoV-2 infected cat exhibited severe inflammation 159 in the distal trachea at 4 dpi characterized by multifocal areas of submucosal necrosis and 160 fibrinoid vasculitis with multifocal areas of mucosal ulceration and diphtheritic membrane 161 formation (Fig 2 G) . 162

Similar histologic features of DAD were also observed in the lungs of SARS-CoV-2-infected 163 cats at 8 dpi, however, the overall pattern of lung injury appeared exhibited more prominent 164 features of vascular injury compared to day 4 (Fig 2 H) . A significant degree of pulmonary 165 edema/exudate, perivascular inflammatory infiltration, and alveolar histiocytosis was present in 166 100% of SARS-CoV-2 animals (6/6 cats) at 8 dpi (Supporting Information). Alveolar damage 167 and necrosis (4/6 cats) and intra-alveolar fibrin (3/6 cats) were also prominent features at this 168 time point. Moreover, histologic evidence of fibrinoid vasculitis (2/6 cats) and vascular 169 thrombosis (2/6 cats) was also observed at 8 dpi, in addition to occasional viral syncytia (1/6 170 cats) (Fig 2H) . In 2 of these cats, the tracheal submucosa was multifocally expanded and effaced 171 by moderate to severe lymphoplasmacytic, histiocytic, and neutrophilic inflammation with 172 necrosis (Fig 2 I) . the TBLN, however, no positive cells were observed in lungs of these animals. (Fig 3) . 186

SARS-CoV-2 viral RNA and fACE2 RNA expression was quantified in the nasal 188 turbinates, TBLN, distal trachea, kidneys and lungs of all SARS-CoV-2-infected cats (n=12) and 189

sham-inoculated controls (n=6) using ddPCR (Fig 4 and S3 Table) . Viral RNA was detected in 190 100% of tissues collected on 4 dpi from SARS-CoV-2-infected cats (Fig 4 A) . At 8 dpi, viral 191 RNA was also detectable in the lung, TBLN, and kidney tissues of all (6/6) infected cats, and in 192 5/6 cats in the nasal turbinates and 5/6 cats in the distal trachea. No SARS-CoV-2 viral RNA was 193 detected in tissues collected from sham-inoculated cats at either time point (S3 Table) . CoV-2 viral RNA copies were elevated in the TBLN at 8 dpi compared with day 4 samples, 195 although this trend was not significant (p=0.0567). In contrast, SARS-CoV-2 viral load in lung 196 samples was significantly lower at 8 dpi than at 4 dpi (p=0.0007) ( In sham-inoculated cats, Kruskal Wallis test revealed that fACE2 RNA in the nasal 201 turbinates was significantly higher than in the lung (p=0.0093) and TBLN (p=0.0049). fACE2 202 RNA was also higher in the kidney when compared to lung (p=0.0003), trachea (p=0.0034), and 203 TBLN (p=0.0001). These findings were similar in SARS-CoV-2-infected animals at 4 and 8 dpi, 204 with fACE2 RNA levels being significantly higher in the nasal turbinates and kidney versus 205 other tissues (p<0.05) (S4 Table) . Overall, fACE2 RNA in the kidney was significantly increased cough, lethargy and increased respiratory effort, with lethargy and increased respiratory effort 234 being the most notable clinical signs (Fig 1) . 235

In addition to clinical signs of lower respiratory and systemic disease, SARS-CoV-2 236 infected cats also exhibited conspicuous pulmonary lesions of diffuse alveolar damage (DAD) by 237 4 dpi, and additional evidence of vascular damage by 8 dpi (Fig 2) . procedures, all study animals were anesthetized to minimize animal suffering and distress. 306

Human euthanasia procedures were conducted by phenobarbital overdose in accordance with 307

Euthanasia of Animals. Prior to euthanasia, all study animals were anesthetized by intramuscular 309 injection of ketamine (4 mg/kg), dexmedetomidine (0.02 mg/kg), and butorphanol (0.4 mg/kg). 310

No animals died without euthanasia during this study. 311

Virus. SARS-CoV-2 virus isolate USA-WA1/2020 was obtained from BEI Resources, passaged 312 up to 6 times in Vero E6 cells in Vero E6 cell growth medium. Virus stock was titrated and 313 quantified on Vero E6 cells using a standard MERS-CoV quantification assay (45). TCID50 was 314 calculated using the Reed and Muench method. 315

Animals. Eighteen adult (9 males, 9 females, all 9 months-old) specific pathogen free (SPF) cats 316

were obtained from Marshall BioResources (North Rose, NY). Animals intended for SARS-317

Oklahoma State University, individually housed and fed dry/wet food with access to water ad 319 libitum. Animals intended for sham-inoculation were group-housed within the AAALAC 320

International Accredited animal facility at Oklahoma State University. Animals were allowed 30 321 days for acclimation prior to initiation of the study. Temperature-sensing microchips (Bio Medic 322 Data Systems, Seaford, DE) were implanted subcutaneously in the dorsum after 30 days. 323

Baseline weights, body temperatures, clinical evaluation, and nasal swab sampling were obtained 324 prior to inoculation. All animals were in apparent good health at the onset of the study. 325

Virus Challenge. Cats were lightly anesthetized with ketamine (4 mg/kg), dexmedetomidine (20 326 µg/kg), and butorphanol (0.4 mg/kg) intramuscularly. Cats were then positioned in ventral 327 recumbency and intubated so that the end of an endotracheal tube is positioned within the distal 328 trachea as described (46). In twelve cats, a 3-cc syringe was used to inoculate 1 mL 9x10 5 PFU 329 (1.26x10 6 TCID50) per mL SARS-CoV-2, isolate USA-WA1/2020 in Dulbecco's Modified Eagle 330

Medium (DMEM), followed by 2 mL of air from an empty syringe. The remaining six cats were 331 sham-inoculated using sterile PBS via the same method. Viral inoculum dosage was confirmed 332 through virus back-titration on E6 cells immediately following inoculation. 333

Sampling. Blood and nasal swab samples were collected under sedation (described above) from 334 all study animals (n=18) at day 0 to serve as baseline for ddPCR analysis. Blood samples (6 mL) 335

were obtained from all cats via cephalic or medial saphenous venipuncture and processed 336

immediately for viral quantification. Nasal swab samples obtained from the nares of all cats 337 Each factor was assigned a score of 0 (normal), 1 (mild-moderate), or 2 (severe) as described in 350 Table 1 . Each clinical factor parameter was added to assign an individual animal a summed 351 clinical score every 24 hours for the duration of the study. Cats were observed at rest for 352 respiration rates, activity levels and other notable clinical signs before stimulation. Necropsy tissues were evaluated for evidence of inflammation and/or aberrations in lymphoid 363 populations as reported in human COVID-19 patients (34-37). Lung tissues were specifically 364 evaluated for the following pathology: alveolar damage (pneumocyte necrosis, hyaline 365 membrane formation,) alveolar fibrin deposition (± organization), serous exudate/edema, 366 perivascular infiltrates, alveolar histiocytes, type II pneumocyte hyperplasia, syncytia, 367 thrombosis, and fibrinoid vasculitis. All tissues were assigned a quantitative histologic score 368 based on previously documented criteria (47, 48): 0 = no apparent pathology/change; 1 = 369 minimal change (minimally increased numbers of inflammatory cells); 2 = mild change (mild 370 inflammatory infiltrates, alveolar damage/necrosis, fibrin deposition and/or exudation); 3 = 371 moderate change (as previously described, but more moderately extensive); 4 = marked changes 372 (as previously described, but with severe inflammation, alveolar damage, hyaline membrane 373 formation, necrosis, exudation, vasculitis and/or thrombosis). All tissues were evaluated and 374 scored by a board-certified veterinary pathologist blinded to study groups to ensure scientific 375 rigor and reproducibility. were assessed using the feline respiratory disease clinical scoring system (see Table 1 )

Clinical parameters summated to provide an overall clinical score per cat per day. Clinical 607 disease severity peaked on 4 dpi and was significantly higher than sham-inoculated cats on 4 dpi 608 (p=0.0054), 5 dpi (p=0.0257), 6 dpi (p=0.0004), and 8 dpi (p=0.0453). A noticeable trend in 609 severity was also noted on 7 dpi as compared with sham-inoculated controls (p=0.0654). (B) 610

World Health Organization Coronavirus (COVID-19) Dashboard: World Health 447 Organization

Risk factors associated with acute 449 respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia 450 in Wuhan, China. JAMA internal medicine

Clinical and immunologic features 452 in severe and moderate Coronavirus Disease 2019. The Journal of Clinical Investigation

CoV-2: a storm is raging. The Journal of Clinical Investigation

Selection of animal models for COVID-19 457 research

Animal models for SARS and MERS coronaviruses

The protein expression 461 profile of ACE2 in human tissues

COVID-19 463 pandemic: current knowledge about the role of pets and other animals in disease 464 transmission

SARS-CoV-2 infection in farmed minks, the Netherlands

Reported Cases of SARS-CoV-2 Infection in Companion Animals

Clinical and Pathological Findings in SARS-CoV-2 Disease Outbreaks in Farmed Mink 473 (Neovison vison)

Spike protein recognition of mammalian ACE2 predicts the 475 host range and an optimized ACE2 for SARS-CoV-2 infection

Functional and genetic analysis of viral 478 receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2

Highly conserved binding region of 481 ACE2 as a receptor for SARS-CoV-2 between humans and mammals

Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx Zoo. mBio

Susceptibility of ferrets, cats, 487 dogs, and other domesticated animals to SARS-coronavirus 2

A serological survey of SARS-489

CoV-2 in cat in Wuhan

The search for a COVID-19 animal model

Transmission Route of SARS-CoV-2? Pathogens

The cat as a 495 model for human obesity: insights into depot-specific inflammation associated with feline 496 obesity

Animal models of disease: classification and etiology of diabetes in 498 dogs and cats

The Burmese cat as a genetic model of type 2 500 diabetes in humans

The cat as a model for human obesity and diabetes

Model with Pulmonary Hypertension and Compromised Pulmonary Function

Human heart failure with preserved ejection versus 507 feline cardiomyopathy: what can we learn from both veterinary and human medicine?

SARS-CoV-2 infection, disease and transmission in domestic cats

Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, 514 transmission, and response to reexposure in cats

Experimental re-infected cats do not transmit SARS-CoV-2

Pathology of experimental SARS coronavirus infection in cats and ferrets

The pathology and 523 pathogenesis of experimental severe acute respiratory syndrome and influenza in animal 524 models

Ensuring animal 526 welfare while meeting scientific aims using a murine pneumonia model of septic shock

Efficacy of 529 pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or 530

Mycoplasma infections

Acute pain in cats: Recent advances in clinical assessment

A systematic review of pathological 534 findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease 535 progression

Pathological study of the 2019 novel 537 coronavirus disease (COVID-19) through postmortem core biopsies

Histopathology and genetic susceptibility in COVID-19 540 pneumonia

Pathological findings of COVID-19 542 associated with acute respiratory distress syndrome. The Lancet respiratory medicine

Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal 546 and intratracheal routes of inoculation

Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel 549 routes of virus spread within and between hosts

Clinicopathologic and radiographic 551 features and etiologic agents in cats with histologically confirmed infectious pneumonia: 39 552 cases (1991-2000)

COVID-19): A 555 Review

associated with acute respiratory distress syndrome

Pulmonary 559 and cardiac pathology in African American patients with COVID-19: an autopsy series from 560

New Orleans

COVID-19 562 pulmonary pathology: a multi-institutional autopsy cohort from Italy

Growth and quantification of MERS-CoV infection. Current 565 protocols in microbiology

Constitutive expression of 567 types 1 and 2 cytokines by alveolar macrophages from feline immunodeficiency virus-568 infected cats

Strain-specific viral distribution and neuropathology of feline immunodeficiency virus

Pathogenesis of oral FIV infection

Assessment of the direct 575 quantitation of SARS-CoV-2 by droplet digital PCR

Parallelised sequence similarity--A Hadoop MapReducable basic local alignment search tool

Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not 581

The American journal of pathology

Lethargy and increased respiratory effort were the most prominent clinical signs

SARS-CoV-2-infected cats; both of which were significantly increased between days 3 and 4 612 (p=0.0027; p=0.0027) and remained significantly elevated in infected cats after 4 dpi as 613 compared to day 0. Coughing was most prominent on 4 dpi and was identified in 4/12 infected 614 cats

Statistical comparisons made via mixed effects analysis. *p<0

Pathologic features of acute SARS-CoV-2 infection in cats are analogous to the 619 exudative phase of COVID-19. Compared to lungs from healthy sham-inoculated cats (A), the 620 lungs of SARS-CoV-2-infected cats were diffusely consolidated

The lungs of healthy, uninfected cats (D) were histologically normal, 622 with open alveoli and minimal atelectasis

exhibited discrete foci of alveolar inflammation and necrosis with fibrin deposition (✱)

increased alveolar macrophages (arrowhead), perivascular lymphocytes (☆), and type II 625

The alveoli in these cats' lungs were frequently filled with 626 large amounts of edema and fibrin strands (E inset), and there were multifocal areas of hyaline 627 membrane formation (F) (✱). The distal trachea of 1 SARS-CoV-2

multifocally ulcerated at 4 dpi (arrow) with diphtheritic membrane formation (arrowhead) and 629

At 8 dpi (H), fibrinoid 630 vasculitis, vascular thrombosis (arrow), and occasional syncytial cells (H inset) were observed in 631 addition to the histopathologic changes described above

were characterized by varying degrees of lymphoplasmacytic, histiocytic, and neutrophilic 633 inflammation with multifocal areas of submucosal necrosis. Magnification: (D, H) 10x

G, H inset, I) 40x, scale bar = 25µm; (F) 60x, 635 scale bar = 17µm

Fluorescent immunohistochemistry for SARS-CoV-2 nucleoprotein identifies 638 mononuclear cells in tracheobronchial lymph node of intratracheally-infected cats. Low 639 numbers of SARS-CoV-2 positive cells (green, white arrows) are detected in (A) positive control 640 tissue (lung) from an African Green Monkey infected with SARS-CoV-2 (51

mononuclear cells in the TB LN of SARS-CoV-2 infected cats (green, white arrow)

DAPI/nuclei; green = CoV-2. Magnification (A-B) 40x, scale bar = 20 µm

Fig 4. fACE2 RNA and SARS-CoV-2 viral RNA quantification in feline tissues. Extraction 645 of SARS-CoV-2 and ACE2 RNA was performed as described from tissues samples collected on 646 either 4 or 8 dpi. Tissue samples included nasal turbinates

A) SARS-CoV-2 RNA copies were detected in all tissues 648 collected from cats inoculated with SARS-CoV-2. No viral RNA was detected in tissues from 649 sham-inoculated cats. In SARS-CoV-2-infected cats, viral RNA copies were slightly increased in 650 the TB LN between 4 to 8 dpi (p=0.0567) while viral RNA load in the lungs significantly 651 decreased over the same period (p=0.0007). (B) fACE2 receptor RNA is significantly increased 652 in the kidney of SARS-CoV-2 infected cats at 4 dpi compared to sham

n=6 cats per group. Statistical comparisons made via two-way ANOVA. ***p<0

were analyzed using QuantaSoft™ v1 AnalysisPro Software (Bio-Rad) and expressed as Log10 398 (copies/mL). 399Feline ACE2 Analysis. Feline angiotensin converting enzyme 2 (fACE2) RNA was quantified 400 by ddPCR using methods similar to the above assay for CoV. RNA was extracted from frozen 401 necropsy tissues as outlined above. cDNA was synthesized as previously published (48). Design 402 of primers and probe targeting fACE2 was performed according to manufacturer's 403 recommendation, namely keeping GC content between 50-60 % for primers and 30-80 % for 404 probes, and melting temperatures between 50-65 •C for primers and 3-10 •C higher for probes. Droplets were read and analyzed as described above. 416Immunohistochemistry. 5µm sections of formalin-fixed, paraffin-embedded lung were 417 mounted on charged glass slides, baked for one hour at 60°C, and passed through Xylene, graded 418 ethanol, and double distilled water to remove paraffin and rehydrate tissue sections. A 419 21 microwave was used for heat induced epitope retrieval. Slides were heated in a high pH solution 420

Labs H-3300) where they were allowed to cool to room temperature. Sections were washed in a 422 solution of phosphate-buffered saline and fish gelatin (PBS-FSG) and transferred to a humidified 423 chamber, for staining at room temperature. Tissues were blocked with 10% normal goat serum 424 Sai Narayanan with the Oklahoma Animal Disease Diagnostic Lab for their assistance in viral